Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-28 Sale |
2020-12-29 9:14 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
19,500 | $69.6 | $1,357,184 | 355,876 (Direct) |
View |
| 2020-12-15 Sale |
2020-12-16 7:27 pm |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
26,294 | $111.77 | $2,938,796 | 113,247 (Direct) |
View |
| 2020-11-24 Sale |
2020-11-25 9:54 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
5,000 | $47.04 | $235,181 | 539,310 (Direct) |
View |
| 2020-11-11 Sale |
2020-11-13 5:00 pm |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
13,410 | $74.51 | $999,227 | 50,621 (Direct) |
View |
| 2020-11-05 Sale |
2020-11-09 4:05 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $42.05 | $105,125 | 280,568 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-03 4:05 pm |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
12,500 | $70.72 | $883,954 | 154,451 (Direct) |
View |
| 2020-09-30 Sale |
2020-10-02 7:57 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
14,500 | $37.69 | $546,458 | 382,876 (Direct) |
View |
| 2020-09-18 Sale |
2020-09-22 7:07 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $42.01 | $105,024 | 285,568 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-16 6:38 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $37.06 | $92,652 | 288,068 (Direct) |
View |
| 2020-09-11 Sale |
2020-09-15 4:05 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $35.02 | $70,047 | 56,334 (Direct) |
View |
| 2020-09-10 Sale |
2020-09-11 4:05 pm |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
2,500 | $47 | $117,500 | 86,951 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 7:45 pm |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
10,000 | $39.94 | $399,450 | 150,531 (Direct) |
View |
| 2020-06-30 Sale |
2020-07-02 4:28 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
10,000 | $32.66 | $326,623 | 123,631 (Direct) |
View |
| 2020-05-26 Sale |
2020-05-28 4:05 pm |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
2,500 | $47 | $117,500 | 94,075 (Direct) |
View |
| 2020-05-01 Sale |
2020-05-05 4:26 pm |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
10,000 | $40.84 | $408,433 | 160,155 (Direct) |
View |
| 2020-04-27 Sale |
2020-04-29 4:05 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $32.01 | $64,028 | 287,823 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-15 Option Award |
2025-01-17 4:35 pm |
N/A 2035-01-15 |
Spyre Therapeutics Inc. | SYRE | Turtle Cameron Chief Executive Officer |
370,000 | $0 | 370,000 (Direct) |
View |
Ownership |
2024-09-06 5:07 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Turtle Cameron Director |
0 | $0 | 94,281 (Indirect) |
View |
| 2024-02-15 Option Award |
2024-02-20 9:21 pm |
N/A N/A |
Spyre Therapeutics Inc. | SYRE | Turtle Cameron Chief Executive Officer |
400 | $9.82 | 746,907 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 8:31 pm |
N/A 2034-02-01 |
Spyre Therapeutics Inc. | SYRE | Turtle Cameron Chief Executive Officer |
277,750 | $0 | 277,750 (Direct) |
View |
| 2023-11-24 Conversion |
2023-11-27 4:25 pm |
N/A N/A |
Spyre Therapeutics Inc. | AGLE | Turtle Cameron Chief Executive Officer |
741,526 | $0 | 1,120,507 (Direct) |
View |
| 2023-11-22 Option Award |
2023-11-27 4:25 pm |
N/A 2033-11-22 |
Spyre Therapeutics Inc. | AGLE | Turtle Cameron Chief Executive Officer |
374,000 | $0 | 1,120,507 (Direct) |
View |
Ownership |
2023-06-30 5:14 pm |
N/A N/A |
Aeglea BioTherapeutics Inc. | AGLE | Turtle Cameron Chief Operating Officer |
0 | $0 | 65,959,896 (Direct) |
View |
| 2021-01-26 Equity Swap |
2021-01-28 7:15 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
50,699 | $0 | 0 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 9:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
6,000 | $0.16 | 355,876 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 9:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
7,500 | $17 | 355,876 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 9:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
6,000 | $0.34 | 355,876 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 9:14 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
19,500 | $0 | 355,876 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-16 7:27 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
4,451 | $17 | 113,247 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-16 7:27 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
21,843 | $13.2 | 113,247 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-16 7:27 pm |
N/A 2028-06-20 |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
26,294 | $0 | 113,247 (Direct) |
View |
| 2020-11-24 Exercise |
2020-11-25 9:54 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
5,000 | $17 | 539,310 (Direct) |
View |
| 2020-11-24 Exercise |
2020-11-25 9:54 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
5,000 | $0 | 539,310 (Direct) |
View |
| 2020-11-11 Gift |
2020-11-13 5:00 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
1,500 | $0 | 50,621 (Direct) |
View |
| 2020-11-05 Exercise |
2020-11-09 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $17 | 280,568 (Direct) |
View |
| 2020-11-05 Exercise |
2020-11-09 4:05 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $0 | 280,568 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-03 4:05 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
5,000 | $13.2 | 154,451 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-03 4:05 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
2,500 | $17 | 154,451 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-03 4:05 pm |
N/A 2028-11-05 |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
7,500 | $0 | 154,451 (Direct) |
View |
| 2020-09-30 Exercise |
2020-10-02 7:57 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
6,000 | $0.16 | 382,876 (Direct) |
View |
| 2020-09-30 Exercise |
2020-10-02 7:57 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $17 | 382,876 (Direct) |
View |
| 2020-09-30 Exercise |
2020-10-02 7:57 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
6,000 | $0.34 | 382,876 (Direct) |
View |
| 2020-09-30 Exercise |
2020-10-02 7:57 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
14,500 | $0 | 382,876 (Direct) |
View |
| 2020-09-18 Exercise |
2020-09-22 7:07 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $17 | 285,568 (Direct) |
View |
| 2020-09-18 Exercise |
2020-09-22 7:07 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $0 | 285,568 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-16 6:38 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $17 | 288,068 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-16 6:38 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $0 | 288,068 (Direct) |
View |
| 2020-09-11 Exercise |
2020-09-15 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $0.34 | 56,334 (Direct) |
View |
| 2020-09-11 Exercise |
2020-09-15 4:05 pm |
2020-05-19 2029-07-14 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $0 | 56,334 (Direct) |
View |
| 2020-09-10 Exercise |
2020-09-11 4:05 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
2,500 | $17 | 86,951 (Direct) |
View |
| 2020-09-10 Exercise |
2020-09-11 4:05 pm |
N/A 2028-06-20 |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
2,500 | $0 | 86,951 (Direct) |
View |
| 2020-09-01 Option Award |
2020-09-02 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,745 | $0 | 12,568 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 7:45 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
5,000 | $13.2 | 150,531 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 7:45 pm |
N/A 2028-11-05 |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
5,000 | $0 | 150,531 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-02 4:28 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
6,000 | $0.16 | 123,631 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-02 4:28 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
4,000 | $0.34 | 123,631 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-02 4:28 pm |
2020-05-19 2029-05-23 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
10,000 | $0 | 123,631 (Direct) |
View |
| 2020-05-31 Option Award |
2020-06-05 4:06 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
376 | $41.57 | 75,531 (Direct) |
View |
| 2020-05-26 Exercise |
2020-05-28 4:05 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
2,500 | $17 | 94,075 (Direct) |
View |
| 2020-05-26 Exercise |
2020-05-28 4:05 pm |
N/A 2028-06-20 |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
2,500 | $0 | 94,075 (Direct) |
View |
| 2020-05-19 Option Award |
2020-05-21 4:26 pm |
2020-05-19 2027-08-23 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
124,890 | $0 | 124,890 (Direct) |
View |
| 2020-05-01 Exercise |
2020-05-05 4:26 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
5,000 | $13.2 | 160,155 (Direct) |
View |
| 2020-05-01 Exercise |
2020-05-05 4:26 pm |
N/A 2028-11-05 |
Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer |
5,000 | $0 | 160,155 (Direct) |
View |
| 2020-04-27 Exercise |
2020-04-29 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $17 | 287,823 (Direct) |
View |
| 2020-04-27 Exercise |
2020-04-29 4:05 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $0 | 287,823 (Direct) |
View |